{"id":"W2055340037","doi":"10.1158/1078-0432.ccr-14-1770","title":"Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Cyclophosphamide; Oncolytic virus; Medicine; Peripheral blood mononuclear cell; Neutralizing antibody; Titer; Antibody; Immunology; Immune system; Virology; Pharmacology; Chemotherapy; Internal medicine; Biology; In vitro","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006553474,0.001135842,0.001238713,0.0003556323,0.0002754702,0.0007247992,0.0007590671,0.001070868,0.001976169],"category_scores_gemma":[0.0003095961,0.0002675208,0.0007303481,0.0003028359,0.000654916,0.0004380395,0.0002653031,0.002232613,0.000341602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008430981,"about_ca_system_score_gemma":0.001321978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008065,"about_ca_topic_score_gemma":0.001547675,"domain_scores_codex":[0.9997732,0.00006991218,0.00001227577,0.00005110199,0.0000209523,0.00007257581],"domain_scores_gemma":[0.9997377,0.00003869096,0.00006644867,0.00003202333,0.0000190669,0.0001059767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4029796,0.1047458,0.004404217,0.001284668,0.001000819,0.0003323405,0.000370495,0.008454257,0.3218982,0.000830683,0.002906755,0.1507921],"study_design_scores_gemma":[0.2237107,0.7138849,0.004802098,0.00005336429,0.0004081662,0.0002821604,0.00004474131,0.002341411,0.05155068,0.0001984529,0.002698474,0.00002475392],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949201,0.001325396,0.0006260103,0.0001671585,0.00008337956,0.001550871,0.0003143988,0.00006617238,0.0009465341],"genre_scores_gemma":[0.9930618,0.00112283,0.001627905,0.0002299238,0.00006446243,0.001769575,0.0007473224,0.00001812519,0.001357935],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001976169,"threshold_uncertainty_score":0.00661093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1336147238726371,"score_gpt":0.5301574505187308,"score_spread":0.3965427266460937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}